SINGAPORE - The Health Sciences Authority (HSA) has approved the world's first dengue vaccine Dengvaxia for use in Singapore following a seven-month expedited review of the potential [Read More...]
Dengue fever cases are creeping up again as Singapore enters the traditional peak dengue season, with the number of cases exceeding 200 a week for the fourth [Read More...]
The rising incidence of dengue fever in Asean has prompted health experts to call for a collective regional action to fight the fastest- growing mosquito-borne disease. Read [Read More...]
Read More
The Philippines leads the path to better dengue management with the world's first mass vaccination programme for dengue fever. ADVA is pleased to congratulate Dr. Loreto-Garin, Health Secretary and the people involved for their accomplishment.
The world’s first dengue vaccine, Dengvaxia®, was awarded ‘The Vaccine Breakthrough of 2016’ at the 6th annual Biopharma Industry Awards Event last night. Developed by Sanofi Pasteur, Dengvaxia® is the world’s first vaccine licensed for the prevention of dengue caused by all four serotypes in individuals between nine and 45 years of age.
